tiprankstipranks
Trending News
More News >
IQVIA Holdings Inc (IQV)
NYSE:IQV
US Market

IQVIA Holdings (IQV) Earnings Dates, Call Summary & Reports

Compare
921 Followers

Earnings Data

Report Date
Jul 29, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
2.78
Last Year’s EPS
2.64
Same Quarter Last Year
Moderate Buy
Based on 16 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:May 06, 2025
|
% Change Since: -2.17%
|
Next Earnings Date:Jul 29, 2025
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed sentiment. While IQVIA reported strong revenue and profit growth, particularly in the TAS segment and maintained a strong backlog, the R&DS segment faced challenges with delayed decision-making and funding issues in emerging biotech. The macroeconomic uncertainty and its impact on customer decisions in R&DS remain concerns.
Company Guidance
During IQVIA's First Quarter 2025 Earnings Conference Call, the company reported strong financial performance, achieving revenue of $3.829 billion, a 2.5% increase on a reported basis and a 3.5% increase at constant currency. Adjusted EBITDA rose by 2.4% to $883 million, and adjusted diluted EPS grew 6.3% year-over-year to $2.70. The Technology & Analytics Solutions (TAS) segment demonstrated robust growth, with revenue increasing by 6.4% reported and 7.6% at constant currency, driven by double-digit growth in real-world evidence. R&D Solutions' revenue was up slightly at 0.3% reported and 1.1% at constant currency, while Contract Sales & Medical Solutions saw a decline of 4.2% reported and 2.1% at constant currency. The company's R&DS backlog reached a new record of $31.5 billion, growing 4.8% compared to the previous year. IQVIA raised its full-year revenue guidance by $275 million, now expecting between $16.0 billion and $16.4 billion, with adjusted EBITDA reaffirmed at $3.765 to $3.885 billion and adjusted diluted EPS guidance maintained at $11.70 to $12.10. Despite some near-term challenges, including delayed decision-making by customers and deteriorating funding for early-stage ventures, IQVIA remains confident in the resilience of the life sciences industry and is well-positioned to navigate the current market environment.
Revenue and Profit Growth
IQVIA's total revenue for the first quarter of 2025 exceeded expectations, growing 2.5% on a reported basis and 3.5% at constant currency. Adjusted EBITDA increased by 2.4%, and adjusted diluted EPS grew 6.3% year-over-year.
TAS Segment Outperformance
The Technology & Analytics Solutions (TAS) segment revenue grew 6.4% reported and 7.6% at constant currency, driven by double-digit growth in real-world evidence.
Strong Backlog and Pipeline
IQVIA's R&DS backlog reached a new record of $31.5 billion at the end of the quarter, growing 4.8% year-over-year, with a qualified pipeline up low-single-digits year-over-year.
AI Deployment Progress
IQVIA has progressed in deploying AI agents, with over 20 agents in production. The company plans to scale up to 40 use cases by the end of the year, seeing positive productivity gains.
---

IQVIA Holdings (IQV) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

IQV Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 29, 20252025 (Q2)
2.78 / -
2.64
May 06, 20252025 (Q1)
2.63 / 2.70
2.546.30% (+0.16)
Feb 06, 20252024 (Q4)
3.11 / 3.12
2.849.86% (+0.28)
Oct 31, 20242024 (Q3)
2.82 / 2.84
2.4914.06% (+0.35)
Jul 22, 20242024 (Q2)
2.56 / 2.64
2.438.64% (+0.21)
May 02, 20242024 (Q1)
2.49 / 2.54
2.453.67% (+0.09)
Feb 14, 20242023 (Q4)
2.82 / 2.84
2.782.16% (+0.06)
Nov 01, 20232023 (Q3)
2.44 / 2.49
2.480.40% (+0.01)
Aug 01, 20232023 (Q2)
2.38 / 2.43
2.44-0.41% (>-0.01)
Apr 27, 20232023 (Q1)
2.41 / 2.45
2.47-0.81% (-0.02)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

IQV Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 06, 2025$152.30$146.20-4.01%
Feb 06, 2025$205.44$209.96+2.20%
Oct 31, 2024$216.04$205.82-4.73%
Jul 22, 2024$224.57$245.23+9.20%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does IQVIA Holdings Inc (IQV) report earnings?
IQVIA Holdings Inc (IQV) is schdueled to report earning on Jul 29, 2025, TBA Not Confirmed.
    What is IQVIA Holdings Inc (IQV) earnings time?
    IQVIA Holdings Inc (IQV) earnings time is at Jul 29, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is IQV EPS forecast?
          IQV EPS forecast for the fiscal quarter 2025 (Q2) is 2.78.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis